logo
Closer, Faster, Smarter: How Nearshoring Is Reshaping the Future of U.S. Denim

Closer, Faster, Smarter: How Nearshoring Is Reshaping the Future of U.S. Denim

Yahoo4 days ago
'I don't know the detriments of not producing domestically. It is the only reason the brand exists,' said Carrie Eddmenson, the brand creator of Nashville-based Imogene + Willie.
'Made in the USA' is deeply woven into Imogene + Willie's DNA, shaping its design choices, guiding its merchandising, and serving as the narrative thread that continues to resonate with consumers. However, co-founders Carrie and Matt Eddmenson originally launched the brand 16 years ago as a means of survival.
More from Sourcing Journal
Download SJ Denim's "Made in America" Issue
Why Central America is Central to Hansae's Multi-Country Manufacturing Strategy
MarkWest Denim Enters the Western Market with Saddle-Tested Jeans
'We came from the world of domestic manufacturing, and we were victims, I would say, of the demise of manufacturing and production stateside,' she explained. 'We started the company to at least do our part to rebirth that culture.'
The men's and women's label is one of the few remaining denim-focused brands committed to large-scale U.S. manufacturing—a group that continues to shrink due to cost, demand and limited access to domestic suppliers.
Increasingly, brands are looking for other resources in the Western hemisphere. At Kingpins New York, representatives from brands and mills discussed the benefits and challenges of domestic, the complexity of the denim supply chain and the necessity of adaptive strategies—even if that means crossing borders.
Artistic Milliners' vision for nearshoring in the Americas is becoming a reality. Since 2020, the company has established SFI and Star Fades Studio in California and the SFI factory in Guatemala. In June, the Pakistani vertical denim manufacturer opened AM Mexico, a denim production facility in Parras, Mexico. Clients are encouraged to source fabrics from regional mill partners like Cone Denim—which is just 200 yards away—so that fabrics can stay local and product development can be sped up.
As a multi-country and multi-category company, Melissa Balasa-Flottman, VP of global innovation and design, said Artistic Milliners can help most U.S. brands find the right nearshoring solution. 'Everyone needs the ability to test, react and learn from their customers,' she said.
Cone has large customers that it services out of both hemispheres with factories in Mexico and China, and both have advantages and disadvantages. The company collaborates closely with clients to identify and implement the best solutions for their specific needs. For instance, Steve Maggard, Cone Denim president, said the needle and laundry cost is lower in Asia, but there's less flexibility and purchasing decisions must be made further in advance.
A client may produce 50-60 percent of a long-running, stable program in Asia and respond to what's selling with a smaller percentage of orders from Mexico. It helps neutralize risk. By servicing a portion of orders from Cone's Mexican facilities, clients pay more, but because of the flexibility and the ability to change silhouette, sizing, wash and act on trends closer to market—they have fewer empty shelves.
'Mexico is not the cheapest. China is not the cheapest,' Maggard said. 'For us to be viable and have people willing to pay a little bit higher price, we have to adjust our minimums. We have to be less stringent on and more flexible on the types of orders we're going to take and the amount of style changes that we're willing to make in order to service our customers'
Smaller brands, however, often lack the comfort or experience to operate across multiple countries. Though some of the processes—like navigating customs and understanding government protocols—involve trial and error, Maggard said Cone's expertise allows it to anticipate pitfalls and manage the complexities on behalf of its customers. To reduce risk for its customers, the mill has implemented third-party audits such as the Higg Index, Oritain, and Bluesign. According to Maggard, these well-recognized certifications simplify the onboarding process for brands by minimizing the due diligence required when integrating Cone's supply chain.
Maintaining a global footprint is a smart business strategy, especially in a time of economic uncertainty worldwide. Unstable governments, massive fluctuations in currency and infrastructure such as strikes at ports are all factors to consider for choosing a sourcing destination, he added.
Cone's goal is to maintain a flexible supply chain so that it can pivot and offer options to our customers to avoid a 'catastrophic failure.' Additional partnerships with factories in Cambodia, Sri Lanka, Bangladesh and Egypt support this effort.
Even when they're owned by the same company, transitioning to factories in different regions comes with special considerations. The dye formula may be same, but there are differences in water hardness and minerals. One plant may pull water from a lake, another from a well. Duplications may require some adjustments in the laundry, but Maggard said Cone's technical team has built up expertise on what to anticipate and achieve the desired styles and shades.
Facing reality
While Eddmenson names control, partnership, flexibility, negotiation and constant connection to suppliers as key benefits of domestic production, she strongly believes in the strength of Imogene + Willie's story.
'The heart of the product is most important. The customer understanding the product is most important, the customer feeling good in the product is most important,' she said.
Challenges persist, but over the years, Imogene + Willie has found it increasingly manageable to produce in the U.S., especially as meeting fabric and factory minimums became easier with growth. 'But we also, admittedly, probably live in a bubble when it comes to that,' Eddmenson said, adding that there's a deeply rooted determination in the U.S. to make things work against the odds.
However, the brand is not blind to current challenges facing the denim industry, particularly the lack of sources for U.S.-made denim textiles. 'We probably need to pay attention more to lead times and trends, but we just haven't built the business that way,' Eddmenson said, adding that a lot of the considerations mass brands must contend with each season is foreign to Imogene + Willie.
'We're opening our minds and our hearts to new regions for fabric,' she said.
At the end of this complex supply chain is a customer that still wants cheap jeans.
Regardless of how authentic the story is or the efforts made to produce jeans in the U.S. or nearby countries, Maryellen Ryan, a consultant with over 30 years in the apparel industry, says the average mass-market consumer still won't be willing to pay the premium 'They're not going to pay what we would need to charge,' Ryan said, adding that consumers need to be educated on the value of the garment.
'I would love to see production come back to the States…but unfortunately it boils down to price,' she said.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Why Casella Waste Systems Stock Flopped on Friday
Why Casella Waste Systems Stock Flopped on Friday

Yahoo

time19 minutes ago

  • Yahoo

Why Casella Waste Systems Stock Flopped on Friday

Key Points The company's bottom-line miss in its second quarter was striking. That was compounded by a guidance reduction for full-year profitability. 10 stocks we like better than Casella Waste Systems › Solid waste and recycling management company Casella Waste Systems (NASDAQ: CWST) was surely eager to start its weekend. On Friday, the company published quarterly results that were a dud with investors, who sent its share price down by more than 5%. That was more deeply in the red than the S&P 500 index's 1.6% dive. One big whiff Much of this was because of a fairly wide bottom-line miss in Casella's second quarter, the results of which were published after market close Thursday. In the quarter, Casella booked revenue of over $465 million. So far, so good, as this was more than 23% higher than in the same quarter of 2024. Further down the profit and loss statement, however, the company revealed that its generally accepted accounting principles (GAAP) net income fell to $5.2 million ($0.08 per share) from the year-ago profit of slightly over $7 million. That drop was discouraging enough, but it was exacerbated by the fact that analysts were expecting far better from the company. On average, they were modeling $0.33 per share for bottom-line profitability, although they underestimated revenue with a collective $454 million projection. Acquisitions played a role in Casella's top-line growth, as the company completed six buyouts across the first half of this year. Management also said higher landfill volumes were a catalyst. Notable guidance revisions Outside of the bottom-line miss, Casella's change in guidance was dismaying for investors. Although it raised its outlook for full-year 2025 revenue -- $1.82 billion to $1.84 billion from just under $1.78 billion to a bit over $1.8 billion -- it cut that for profitability. The company now believes its GAAP net income will land at $8 million to $18 million; the previous guidance called for $10 million to $25 million. Should you buy stock in Casella Waste Systems right now? Before you buy stock in Casella Waste Systems, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Casella Waste Systems wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $625,254!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,090,257!* Now, it's worth noting Stock Advisor's total average return is 1,036% — a market-crushing outperformance compared to 181% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 29, 2025 Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Why Casella Waste Systems Stock Flopped on Friday was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Why Novo Nordisk Stock Bumped Higher on Friday
Why Novo Nordisk Stock Bumped Higher on Friday

Yahoo

time21 minutes ago

  • Yahoo

Why Novo Nordisk Stock Bumped Higher on Friday

Key Points The Federal government might boost its support of weight-loss drugs soon. According to a media report, it's contemplating a five-year, experimental program that would subsidize their costs for qualifying patients. 10 stocks we like better than Novo Nordisk › Unexpected news of a potential support program from the federal government boosted the share prices of weight-loss drug developers on Friday. The poster boy for that still rather small group, Wegovy/Ozempic maker Novo Nordisk (NYSE: NVO), understandably saw a stock price lift that day. It rose by more than 2%, contrasting well with the 1.6% slide of the S&P 500 index. Federal help for obesity drugs? That news came from The Washington Post, which published an article stating that the Trump administration is planning an experimental program that would cover the costs of such medications. Citing documents from the Centers for Medicare and Medicaid Services (CMS) it had obtained, the newspaper said the plan would be implemented by state Medicaid administrations. It would also be utilized by Medicare Part D insurance plans. These entities would be allowed to cover weight-loss drugs for qualifying patients. At the moment, Medicare generally covers such treatments for patients who suffer from type 2 diabetes. Both Novo Nordisk's Wegovy and rival Eli Lilly's Zepbound are essentially versions of predecessor diabetes drugs. Some private insurance plans cover obesity medications. The Post wrote that the experimental program will last for five years. Massive potential impact Novo Nordisk hasn't yet commented on the article, but we can be sure the company is excited about the prospect. Combined, Medicare and Medicaid are immense programs. Even if only a few states are willing to cover weight-loss treatments through them, the company could experience a surge in sales. For the stock's investors, this is a potentially very impactful development well worth monitoring. Should you buy stock in Novo Nordisk right now? Before you buy stock in Novo Nordisk, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Novo Nordisk wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $625,254!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,090,257!* Now, it's worth noting Stock Advisor's total average return is 1,036% — a market-crushing outperformance compared to 181% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 29, 2025 Eric Volkman has no position in any of the stocks mentioned. The Motley Fool recommends Novo Nordisk. The Motley Fool has a disclosure policy. Why Novo Nordisk Stock Bumped Higher on Friday was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Addus HomeCare (ADUS) Q2 Earnings: What To Expect
Addus HomeCare (ADUS) Q2 Earnings: What To Expect

Yahoo

time22 minutes ago

  • Yahoo

Addus HomeCare (ADUS) Q2 Earnings: What To Expect

Home healthcare provider Addus HomeCare (NASDAQ:ADUS) will be reporting results this Monday afternoon. Here's what you need to know. Addus HomeCare missed analysts' revenue expectations by 0.6% last quarter, reporting revenues of $337.7 million, up 20.3% year on year. It was a mixed quarter for the company, with a narrow beat of analysts' sales volume estimates. Is Addus HomeCare a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Addus HomeCare's revenue to grow 20.8% year on year to $346.5 million, improving from the 10.4% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.46 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Addus HomeCare has missed Wall Street's revenue estimates three times over the last two years. Looking at Addus HomeCare's peers in the senior health, home health & hospice segment, some have already reported their Q2 results, giving us a hint as to what we can expect. BrightSpring Health Services delivered year-on-year revenue growth of 15.3%, beating analysts' expectations by 5.2%, and Option Care Health reported revenues up 15.4%, topping estimates by 4.6%. Option Care Health traded down 2.7% following the results. Read our full analysis of BrightSpring Health Services's results here and Option Care Health's results here. The euphoria surrounding Trump's November win lit a fire under major indices, but potential tariffs have caused the market to do a 180 in 2025. While some of the senior health, home health & hospice stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 4.3% on average over the last month. Addus HomeCare is down 5.3% during the same time and is heading into earnings with an average analyst price target of $136.45 (compared to the current share price of $104.74). Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store